Dawnrays Pharmaceutical (Holdings) (2348.HK) Earnings Analysis
Dawnrays Pharmaceutical (Holdings) (2348.HK) next reports earnings on 2026-08-21. Trailing P/E 6.17.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2348.HK next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2348.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-23 | 0.3524 HKD | n/a | n/a | n/a |
2348.HK valuation and analyst view
| Trailing P/E | 6.17 |
|---|---|
| Trailing EPS | 0.13773 HKD |
| Price / book | 0.40 |
| Dividend yield | 6.30% |
| Market cap | 1.50B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dawnrays Pharmaceutical (Holdings) (2348.HK)'s next earnings date?
Dawnrays Pharmaceutical (Holdings) is next scheduled to report on 2026-08-21.
Did 2348.HK beat earnings last quarter?
Consensus estimate data was not available for 2348.HK's 2024-08-23 report.
What is 2348.HK's current P/E ratio and EPS?
2348.HK trades at a trailing P/E of 6.17 on trailing EPS of 0.13773091031646603 HKD.
What do analysts rate 2348.HK?
2348.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.